Courts / Ireland / Report
Patent dispute between pharma giants comes before Irish court
2016-11-08
Hearing Or Decision
Summary
A patent dispute between pharmaceutical companies has been admitted to the fast track Commercial Court list. Belgian-based GlaxoSmithKline Biologicals SA, part of the Glaxo SmithKline group, sued Pfizer Ireland Pharmaceuticals and Pfizer Inc over alleged infringement of a meningitis vaccine called TRUMENBA and its protein components. GlaxoSmithKline alleges that Pfizer Ireland manufactures the product in Ireland at the direction of Pfizer Inc, constituting a breach of four patents. The applicant seeks an injunction restraining the defendants from infringing these patents, orders to hand over or destroy allegedly infringing products, discovery of the names of parties supplied with such products, and damages. The matter was heard by Mr Justice Brian Cregan, who admitted the action to the fast track list. Counsel for GlaxoSmithKline, Michael Howard, stated there was consent to this admission. The procedural stage is a hearing or decision regarding the admission to the list, not a final judgment on the merits of the infringement claims.
Who, what, where, when and why
What: Report matter: Patent dispute between pharma giants comes before Irish court. Procedural stage: hearing_or_decision
When:
- 2016-11-08 Publication
Case subjects
Applicant
Applicant
Topics
Help us improve this report
Your request is saved for the newsroom's next review. It does not immediately change the published report.
Prefer email? Send a correction request.